COPD, also known as chronic obstructive pulmonary disease, is a progressive lung disease that can cause persistent cough, wheezing, shortness of breath, excess mucus production, and frequent upper respiratory infections.
Treatment is often comprised of a variety of medications, and we have a new one to add to the list—Trelegy Ellipta—a once-daily single inhaler.
What is Trelegy Ellipta indicated for?
Trelegy Ellipta is a once-daily combination inhaler indicated for long-term treatment of patients with COPD, including chronic bronchitis and/or emphysema. See More